anti-ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) 抗体

ADAMTS13 encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. 再加上,我们可以发ADAMTS13 试剂盒 (36)ADAMTS13 蛋白 (6)和数多这个蛋白质的别的产品。

列出全部抗体 基因 基因ID UniProt
ADAMTS13 11093 Q76LX8
ADAMTS13 279028 Q769J6
ADAMTS13 102554393  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • 在线下订单
  • orders@antibodies-online.cn

antibodies-online.cn销售最多的anti-ADAMTS13 抗体

Showing 10 out of 109 products:

产品编号 适用 宿主 标记 应用范围 图像 规格 供应商 交付 价格 详细
非结合性 EIA, IHC (p), WB <strong>Immunohistochemistry:</strong> ADAMTS13 antibody staining of Formalin-Fixed Paraffin-Embedded Human hepatocarcinoma followed by peroxidase-conjugation to the secondary antibody and DAB staining. <strong>Western blot analysis:</strong> ADAMTS13 antibody staining of CEM cell line lysates (35 µg/lane). ADAMTS13 (arrow) was detected using the purified Pab. 0.4 mL Log in to see 6至8个工作日
$390.50
详细
非结合性 IHC (p), WB Western blot analysis of anti-ADAMTS13 Antibody (Center)(ABIN391641) in CEM cell line lysates (35 µg/lane). ADAMTS13 (arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human hepatocarcinoma with ADAMTS13 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Log in to see 10至11个工作日
$324.50
详细
非结合性 WB Detection of Recombinant Human Adam-TS13 by Western Blot. Samples: Purified recombinant Adam-TS13. Antibody: ABIN152016 used at the indicated concentrations. Detection: Chemiluminescence with an exposure time of approximately 30 seconds. Western Blot: ADAMTS13 Antibody  - Purified recombinant Adam-TS13. Antibody used at the indicated concentrations. 100 μL Log in to see 7至9个工作日
$486.94
详细
山羊 非结合性 WB 100 μL Log in to see 7至9个工作日
$486.94
详细
山羊 非结合性 IP, WB 100 μL Log in to see 7至9个工作日
$486.94
详细
非结合性 ELISA, WB   100 μg Log in to see 4至6个工作日
$240.00
详细
小鼠 非结合性 CyTOF, FACS, IP, WB Detection of ADAMTS13 in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Mouse Anti-Human ADAMTS13 Monoclonal Antibody. To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin. Detection of ADAMTS13 in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Mouse Anti-Human ADAMTS13 Monoclonal Antibody. To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin. 100 μg Log in to see 8至9个工作日
$266.70
详细
非结合性 ELISA, IHC, IHC (p), WB   0.2 mL Log in to see 7至9个工作日
$408.19
详细
小鼠 非结合性 ELISA Detection limit for recombinant GST tagged ADAMTS13 is approximately 0.1 ng/mL as a capture antibody. 0.1 mg Log in to see 8至11个工作日
$450.00
详细
小鼠 非结合性 EIA, WB   0.1 mg Log in to see 6至8个工作日
$500.50
详细

通过反应活性、应用领域、克隆类型和共轭标记 ADAMTS13 抗体

特性 应用范围 宿主 克隆类型 标记
Human , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) , ,


, , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , , ,

引用最多的anti-ADAMTS13 抗体

  1. Human Polyclonal ADAMTS13 Primary Antibody for WB - ABIN152016 : Tao, Wang, Choi, Bernardo, Nishio, Sadler, López, Dong: Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. in Blood 2005 (PubMed)
    Show all 5 Pubmed References

  2. Human Polyclonal ADAMTS13 Primary Antibody for ELISA, IHC - ABIN4278265 : Ganburged, Suda, Saito, Yamazaki, Isokawa, Moriyama: Dilated capillaries, disorganized collagen fibers and differential gene expression in periodontal ligaments of hypomorphic fibrillin-1 mice. in Cell and tissue research 2010 (PubMed)
    Show all 3 Pubmed References

  3. Human Polyclonal ADAMTS13 Primary Antibody for IP, WB - ABIN251718 : Feng, Eyler, Zhang, Maga, Nester, Kroll, Smith, Afshar-Kharghan: Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. in Blood 2013 (PubMed)
    Show all 2 Pubmed References

  4. Human Polyclonal ADAMTS13 Primary Antibody for WB - ABIN251717 : Turner, Nolasco, Ruggeri, Moake: Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. in Blood 2009 (PubMed)

更多抗ADAMTS13的相互作用对抗体

Mouse (Murine) ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) interaction partners

  1. results suggest that ADAMTS13 controls key steps of ischemic vascular remodeling and that recombinant ADAMTS13 is a putative therapeutic avenue for promoting stroke recovery.

  2. ADAMTS13 retards progression of diabetic nephropathy, most likely by inhibiting VWF (显示 VWF 抗体)-dependent intrarenal thrombosis.

  3. administration of ADAMTS13 5 minutes after occlusion dose-dependently dissolved these t-PA (显示 PLAT 抗体)-resistant thrombi resulting in fast restoration of MCA (显示 RSPH1 抗体) patency and consequently reduced cerebral infarct sizes

  4. Sleeping beauty transposon-mediated gene therapy achieved sustained expression of transgene ADAMTS13 and long-term prophylaxis against congenital thrombotic thrombocytopenic purpura in Adamts13(-/-) mice.

  5. Results also suggest that Toxoplasma gondii-mediated apoptosis might play a pivotal role and a different type of role in the mechanism of neurodegeneration and neuropathology in the process of toxoplasma encephalitis. Furthermore, expression of ADAMTS-13 might give an idea of the progress and is critical for diagnosis of this disease.

  6. Letter: deficiency of ADAMTS13 results in increased formation of venous thrombosis in mice.

  7. ADAMTS13 substrate specificity

  8. Data indicate that the p.D187H mutation impairs ADAMTS13 activity and secretion and may contribute to thrombotic thrombocytopenic purpura.

  9. Data show that metalloendopeptidase (显示 THOP1 抗体) ADAMTS13 does not directly promote development of adipose tissue.

  10. findings provide further evidence on the pathophysiological role for the ADAMTS13/VWF (显示 VWF 抗体) axis in atherosclerosis

Human ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) interaction partners

  1. Rare genetic variants in the ADAMTS13 on Willebrand factor-binding domain contribute to pediatric stroke.

  2. No correlation was found between VWF (显示 VWF 抗体)/ADAMTS13 and infarct size in patients. Patients suffering from intramyocardial hemorrhage had significantly higher VWF (显示 VWF 抗体) activity and lower ADAMTS13 activity. Intracoronary administration of rADAMTS13 did not decrease infarct size or IMH in a porcine model of myocardial ischaemia-reperfusion, disputing the idea that the imbalance in ADAMTS13 and VWF (显示 VWF 抗体) as the cause of no reflow.

  3. both in acute and chronic cerebrovascular disease patients, ADAMTS13 levels were significantly decreased, with the lowest ADAMTS13 levels found in acute stroke patients. This difference was even more distinct when the ratio of VWF:ADAMTS13 was considered. These results demonstrate the potentially important involvement of the VWF (显示 VWF 抗体)/ADAMTS13 axis in ischemic stroke.

  4. Placental trophoblasts and villous vessel endothelial cells produce a full-length and functional ADAMTS13 protease. Placental expression of ADAMTS13 exhibits a dynamic change during pregnancy, which seems to be inhibited in late pregnancy and in patients with severe preeclampsia.

  5. ADAMTS13 activity appears to be an independent risk factor for incident prediabetes and type 2 diabetes.

  6. both anti-ADAMTS13 IgG antibody and ADAMTS13 antigen levels correlate with outcome in thrombotic thrombocytopenic purpura with increased cardiac and neurological involvement and increased mortality.

  7. Low ADAMTS-13 levels correlated with high levels of NTproBNP but had no independent prognostic significance. In conclusion, high VWF:Ag levels, probably representing endothelial dysfunction, are associated with prognosis in patients with AL amyloidosis, independently of other features of the disease or cardiac biomarkers.

  8. findings highlight the complexity of glycan modifications on ADAMTS13, which may have implications for its interaction with immune- or clearance receptors containing carbohydrate recognition domains.

  9. ADAMTS-13 levels are decreased in plasma of AML (显示 RUNX1 抗体) patients and the level of ADAMTS-13 is related to inflammation and infection of AML (显示 RUNX1 抗体) patients. Besides, low ADAMTS-13 level is one potential risk factor for AML (显示 RUNX1 抗体)

  10. these results demonstrate that HNPs1-3 may be potent inhibitors of ADAMTS13 activity, likely by binding to the central A2 domain of VWF (显示 VWF 抗体) and physically blocking ADAMTS13 binding.

ADAMTS13 抗原简介

蛋白简介

This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene is the von Willebrand Factor (vWF)-cleaving protease, which is responsible for cleaving at the site of Tyr842-Met843 of the vWF molecule. A deficiency of this enzyme is associated with thrombotic thrombocytopenic purpura. Alternative splicing of this gene generates multiple transcript variants encoding different isoforms.

Gene names and symbols associated with ADAMTS13

  • ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) 抗体
  • a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13 (Adamts13) 抗体
  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (adamts13) 抗体
  • ADAM metallopeptidase with thrombospondin type 1 motif 12 (ADAMTS12) 抗体
  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (Adamts13) 抗体
  • ADAM metallopeptidase with thrombospondin type 1 motif 13 (Adamts13) 抗体
  • ADAM-TS13 抗体
  • ADAMTS-13 抗体
  • ADAMTS12 抗体
  • ADAMTS13 抗体
  • C9orf8 抗体
  • Gm710 抗体
  • vWF-CP 抗体
  • VWFCP 抗体

Protein level used designations for ADAMTS13

ADAM metallopeptidase with thrombospondin type 1 motif, 13 , A disintegrin and metalloproteinase with thrombospondin motifs 13 , a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13 , vWF-cleaving protease , von Willebrand factor-cleaving protease , ADAM-TS 13 , ADAM-TS13 , ADAMTS-13 , ADAMTS13 isoform IAP-b , vWF-CP mRNA for von Willebrand factor-cleaving , ADAM metallopeptidase with thrombospondin type 1 motif, 13 isoform 1 preproprotein-like , ADAM metallopeptidase with thrombospondin type 1 motif, 12 , A disintegrin and metalloproteinase with thrombospondin motifs 12 , A disintegrin and metalloproteinase with thrombospondin motifs 13-like , a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13

GENE ID SPECIES
100069281 Equus caballus
11093 Homo sapiens
279028 Mus musculus
532272 Bos taurus
100320289 Danio rerio
479369 Canis lupus familiaris
427428 Gallus gallus
100068281 Equus caballus
461952 Pan troglodytes
525276 Bos taurus
701750 Macaca mulatta
100404947 Callithrix jacchus
100343027 Oryctolagus cuniculus
100481099 Ailuropoda melanoleuca
100226372 Taeniopygia guttata
100630922 Canis lupus familiaris
102554393 Rattus norvegicus
100727045 Cavia porcellus
anti-ADAMTS13 (ADAMTS13) 抗体 精选生产商
您还需要查找其他产品吗?